ELAB
Elevai Labs, Inc. Common Stock
NASDAQ: ELAB · HEALTHCARE · BIOTECHNOLOGY
$2.53
-0.39% today
Updated 2026-04-29
Market cap
$11.08M
P/E ratio
—
P/S ratio
18.78x
EPS (TTM)
$-382.61
Dividend yield
—
52W range
$2 – $269
Volume
9.0M
Elevai Labs, Inc. Common Stock (ELAB) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
-945.00%
ROE
-107.30%
ROA
-40.70%
Debt/equity
0.64x
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2020 | — | $-222910.00 | — | — | — |
| 2021 | $827.00 | $-784739.00 | -244.01% | -94,928.66% | -94,889.84% |
| 2022 | $766277.00 | $-1.80M | 58.37% | -233.37% | -234.94% |
| 2023 | $1.71M | $-4.30M | 66.25% | -219.55% | -251.17% |
| 2024 | $2.47M | $-6.25M | 72.84% | -75.65% | -253.14% |
| 2025 | $590084.00 | $-7.71M | 12.68% | -1,250.11% | -1,306.28% |